223 related articles for article (PubMed ID: 28406091)
41. Muscle pain associated with daptomycin.
Veligandla SR; Louie KR; Malesker MA; Smith PW
Ann Pharmacother; 2004 Nov; 38(11):1860-2. PubMed ID: 15367725
[TBL] [Abstract][Full Text] [Related]
42. Acute Eosinophilic Pneumonia Secondary to Menthol Cigarette Use: A Rare Phenomenon With a Review of Literature.
Harne PS; Rao S; Malik M; Shepherd Z
J Investig Med High Impact Case Rep; 2020; 8():2324709620925978. PubMed ID: 32462944
[TBL] [Abstract][Full Text] [Related]
43. Daptomycin associated eosinophilic pneumonia.
Fernández-González R; Díaz López MD; Lorenzo Vizcaya AM; González Noya A
Med Clin (Barc); 2021 Feb; 156(3):148-149. PubMed ID: 32098706
[No Abstract] [Full Text] [Related]
44. Acute Eosinophilic Pneumonia: Pyrethroid Exposure & Change In Smoking Habit!
Kuriakose K; Klair JS; Johnsrud A; Meena NK
J Ark Med Soc; 2016 Jun; 112(14):282-3. PubMed ID: 27434983
[TBL] [Abstract][Full Text] [Related]
45. Myopathy and eosinophilic pneumonia coincidentally induced by treatment with daptomycin.
Hagiya H; Hasegawa K; Asano K; Terasaka T; Kimura K; Nada T; Nakamura E; Waseda K; Hanayama Y; Otsuka F
Intern Med; 2015; 54(5):525-9. PubMed ID: 25758082
[TBL] [Abstract][Full Text] [Related]
46. Possible daptomycin-induced acute eosinophilic pneumonia in a patient with diabetic foot infection.
Hatipoglu M; Memis A; Turhan V; Mutluoglu M; Canoglu K
Int J Antimicrob Agents; 2016 May; 47(5):414-5. PubMed ID: 27089828
[No Abstract] [Full Text] [Related]
47. [A case of eosinophilic pneumonia due to Nicolase (serrapeptase) after recovery from acute eosinophilic pneumonia].
Kai N; Shirai R; Hirata N; Iwata A; Umeki K; Ishii H; Kishi K; Tokimatsu I; Hiramatsu K; Kadota J
Nihon Kokyuki Gakkai Zasshi; 2009 Mar; 47(3):254-8. PubMed ID: 19348276
[TBL] [Abstract][Full Text] [Related]
48. Do Not Forget Daptomycin as a Cause of Eosinophilic Pneumonia!
John TM; Kontoyiannis DP
Chest; 2021 Apr; 159(4):1687-1688. PubMed ID: 34022008
[No Abstract] [Full Text] [Related]
49. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
Cunha BA; Krol V; Kodali V
Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
[TBL] [Abstract][Full Text] [Related]
50. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
51. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
Kullar R; McClellan I; Geriak M; Sakoulas G
Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Usery JB; Vo NH; Finch CK; Cleveland KO; Gelfand MS; Self TH
Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
[TBL] [Abstract][Full Text] [Related]
54. [Adverse pulmonary drug effects].
Mazur D; Stahlmann R
Dtsch Med Wochenschr; 2008 Jan; 133(3):81-6. PubMed ID: 18186010
[No Abstract] [Full Text] [Related]
55. Daptomycin eosinophilic pneumonia: an adverse effect to be aware of.
Abelenda Alonso G; Montes Rodríguez I; Martín Torres J; Del Valle Loarte P
Rev Esp Quimioter; 2018 Jun; 31(3):282-284. PubMed ID: 29791122
[No Abstract] [Full Text] [Related]
56. Photo quiz. Daptomycin-induced eosinophilic pneumonia.
Fisher LH; Choi J; Bricker RS; Shere-Wolfe KD; Saharia K
Clin Infect Dis; 2015 Sep; 61(6):978-9, 1026-7. PubMed ID: 26316527
[No Abstract] [Full Text] [Related]
57. Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report.
Eckhardt LGJ; Kelley JL; Maes D
BMC Infect Dis; 2022 Nov; 22(1):873. PubMed ID: 36418971
[TBL] [Abstract][Full Text] [Related]
58. Venlafaxine-induced acute eosinophilic pneumonia.
Tsigkaropoulou E; Hatzilia D; Rizos E; Christodoulou C; Loukides S; Papiris S; Lykouras L
Gen Hosp Psychiatry; 2011; 33(4):411.e7-9. PubMed ID: 21762842
[TBL] [Abstract][Full Text] [Related]
59. Daptomycin associated eosinophilic pneumonia: case report and differential diagnoses.
Basnet S; Tachamo N; Dhital R; Tharu B
J Community Hosp Intern Med Perspect; 2018; 8(3):152-155. PubMed ID: 29915657
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of rapid corticosteroid tapering in acute eosinophilic pneumonia patients with initial eosinophilia.
Jhun BW; Kim SJ; Kim K; Lee JE
Respirology; 2015 Nov; 20(8):1241-7. PubMed ID: 26333129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
